Clinical Trial Update: Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 clinical trial evaluating chidamide with antiretroviral therapy for eradicating latent HIV-1 reservoirs has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Chronic HIV Infections | Phase 1, Phase 2 | Status: COMPLETED